Oxidative stress as a multiple effector in Fanconi anaemia clinical phenotype

European Journal of Haematology

Volumn 75, Issue 2, 2005, Pages 93-100

  Pagano, Giovanni ^a   Degan, Paolo ^b   D'Ischia, Marco ^c   Kelly, Frank J ^d   Nobili, Bruno ^e   Pallardó, Federico V ^f   Youssoufian, Hagop ^g   Zatterale, Adriana ^h  

^a Centre for Research Innovation and Technological Transfer in Oncology and Life Sciences   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

^f UNIVERSITY OF VALENCIA   (Spain)

^g ImClone Systems   (United States)

^h Department of Genetics   (Italy)

Author keywords

Bone marrow failure; Cancer; Diabetes; Fanconi anaemia; Malformations; Oxidative stress

Indexed keywords

BUTADIENE DIEPOXIDE; MITOMYCIN C; XENOBIOTIC AGENT;

CELL REGENERATION; CLINICAL FEATURE; CONGENITAL MALFORMATION; CROSS LINKING; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; ENDOCRINE DISEASE; EX VIVO STUDY; FANCONI ANEMIA; HUMAN; IN VITRO STUDY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; HUMANS; NUCLEAR PROTEINS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHENOTYPE;

EID: 22444431937     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2005.00507.x     Document Type: Review

References (76)

1. ALTER BP. Fanconi's anaemia and malignancies. Am J Hematol 1996;53:99-110.
2. AUERBACH AD, WOLMAN SR. Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens. Nature 1976;261:494-496.
3. WAJNRAJCH MP, GERTNER JM, HUMA Z, et al. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anaemia Registry. Pediatrics 2001;107:744-754.
4. ALTER BP. Fanconi's anaemia and its variability. Brit J Haematol 1993;85:9-14.
5. TANIGUCHI T, D'ANDREA AD. Molecular pathogenesis of Fanconi anaemia. Int J Hematol 2002;75:123-128.
6. WANG X, D'ANDREA AD. The interplay of Fanconi anaemia proteins in the DNA damage response. DNA Repair (Amst) 2004;3:1063-1069.
7. MEETEI AR, LEVITUS M, XUE Y, et al. X-linked inheritance of Fanconi anaemia complementation group B. Nature Genet 2004;36:1219-1224.
8. PRITSOS CA, SARTORELLI AC. Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics. Cancer Res 1986;46:3528-3532.
9. DUSRE L, RAJAGOPALAN S, ELIOT HM, COVEY JM, SINHA BK. DNA interstrand cross-link and free radical formation in a human multidrug resistant cell line from mitomycin C and its analogues. Cancer Res 1990;50:648-652.
10. CLARKE AA, PHILPOTT NJ, GORDON-SMITH EC, RUTHERFORD TR. The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking. Br J Haematol 1997;96:240-247.
11. KORKINA LG, DEEVA IB, IACCARINO M, et al. Redox-dependent toxicity of diepoxybutane and mitomycin C in sea urchin embryogenesis. Carcinogenesis 2000;21:213-220.
12. PENKETH PG, HODNICK WF, BELCOURT MF, SHYAM K, SHERMAN DH, SARTORELLI AC. Inhibition of DNA crosslinking by mitomycin C by peroxidase-mediated oxidation of mitomycin C hydroquinone. J Biol Chem 2001;276:34445-34452.
13. PAGANO G, MANINI P, BAGCHI D. Oxidative stress-related mechanisms in chromium(VI)-induced toxicity to Fanconi anaemia cells. Environ Health Persp 2003;111:1699-1703.
14. IYER VN, SZYBALSKI W. Mitomycins and porphyromycin: Chemical mechanism of activation and crosslinking of DNA. Science 1964;145:55-58.
15. KRUYT FA, HOSHINO T, LIU JM, JOSEPH P, JAISWAL AK, YOUSSOUFIAN H. Abnormal microsomal detoxification implicated in Fanconi anaemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. Blood 1998;92:3050-3056.
16. CUMMING RC, LIGHTFOOT J, BEARD K, YOUSSOUFIAN H, O'BRIEN PJ, BUCHWALD M. Fanconi anaemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat Med 2001;7:814-820.
17. REUTER TY, MEDHURST AL, WAISFISZ Q, et al. Yeast two-hybrid screens imply involvement of Fanconi anaemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport. Exp Cell Res 2003;289:211-221.
18. ZANIER R, BRIOT D, VILLARD JA, SARASIN A, ROSSELLI F. Fanconi anaemia C gene product regulates expression of genes involved in differentiation and inflammation. Oncogene 2004;23:5004-5013.
19. MOREL Y, BAROUKI R. Down-regulation of cytochrome P450 1A1 gene promoter by oxidative stress. Critical contribution of nuclear factor 1. J Biol Chem 1998;273:26969-26976.
20. WIRTH D, CHRISTIANS E, MUNAUT C, DESSY C, FOIDART JM, GUSTIN P. Differential heat shock gene hsp70-1 response to toxicants revealed by in vivo study of lungs in transgenic mice. Cell Stress Chaperones 2002;7:387-395.
21. FAVREAU F, PETIT-PARIS I, HAUET T, et al. Cyclooxygenase 1-dependent production of F2-isoprostane and changes in redox status during warm renal ischemia-reperfusion. Free Radic Biol Med 2004;36:1034-1042.
22. FUTAKI M, IGARASHI T, WATANABE S, et al. The FANCG Fanconi anaemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage. Carcinogenesis 2002;23:67-72.
23. PARK SJ, CICCONE SL, BECK BD, et al. Oxidative stress/damage induces multimerization and interaction of Fanconi anaemia proteins. J Biol Chem 2004;279:30053-30059.
24. PAGANO G, YOUSSOUFIAN H. Fanconi's anaemia proteins: Concurrent roles in cell protection against oxidative damage. BioEssays 2003;25:589-595.
25. NORDENSON I. Effect of superoxide dismutase and catalase on spontaneously occuring chromosome breaks in patients with Fanconi's anaemia. Hereditas 1977;86:147-150.
26. PAGANO G, KORKINA LG. Prospects for nutritional interventions in the clinical management of Fanconi anaemia. Cancer Causes Control 2000;11:881-889.
27. TAKEUCHI T, MORIMOTO K. Increased formation of 8-hydroxydeoxyguanosine, an oxidative DNA damage, in lymphoblasts from Fanconi's anaemia patients due to possible catalase deficiency. Carcinogenesis 1993;14:1115-1120.
28. DEGAN P, BONASSI S, DE CATERINA M, et al. In vivo accumulation of 8-hydroxy-2́-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis 1995;16:735-742.
29. PAGANO G, DEGAN P, D'ISCHIA M, et al. Gender- and age-related distinctions for the in vivo prooxidant state in Fanconi anaemia patients. Carcinogenesis 2004;25:1899-1909.
30. KORKINA LG, SAMOCHATOVA EV, MASCHAN AA, SUSLOVA TB, CHEREMISINA ZP, AFANAS'EV IB. Release of active oxygen radicals by leukocytes of Fanconi's anaemia patients. J Leukocyte Biol 1992;52:357-362.
31. JOENJE H, ARWERT F, ERIKSSON AW, DE KONING H, OOSTRA AB. Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia. Nature 1981;290:142-143.
32. FOOT M, GROSS O, EPE B, PFLAUM M, HOEHN H. Cell cycle defect in connection with oxygen and iron sensitivity in Fanconi anaemia lymphoblastoid cells. Exp Cell Res 1996;222:262-268.
33. DALLAPICCOLA B, PORFIRIO B, MOKINI V, ALIMENA G, ISACCHI G, GANDINI E. Effect of oxidants and anti-oxidants on chromosomal breakage in Fanconi anaemia lymphocytes. Hum Genet 1985;69:62-65.
34. NAGASAWA H, LITTLE JB. Suppression of cytotoxic effect of mitomycin-C by superoxide dismutase in Fanconi's anaemia and dyskeratosis congenita fibroblasts. Carcinogenesis 1983;4:795-798.
35. SAADATZADEH MR, BIJANGI-VISHEHSARAEI K, HONG P, BERGMANN H, HANELINE LS. Oxidant hypersensitivity of Fanconi anaemia type C deficient cells is dependent on a redox-regulated apoptotic pathway. J Biol Chem 2004;279:16805-16812.
36. EMERIT I, LEVY A, PAGANO G, PINTO L, CALZONE R, ZATTERALE A. Transferable clastogenic activity in plasma from patients with FA. Hum Genet 1995;96:14-20.
37. SCHULZ JC, SHAHIDI NT. Tumor necrosis factor-α over-production in Fanconi's anaemia. Am J Hematol 1993;42:196-201.
38. DUFOUR C, CORCIONE A, SVAHN J, et al. TNF-α and IFN-γ are over expressed in the bone marrow of Fanconi anaemia patients and TNF-α suppresses erythropoiesis in vitro. Blood 2003;102:2053-2059.
39. PEARL-YAFE M, HALPERIN D, HALEVY A, KALIR H, BIELORAI B, FABIAN I. An oxidative mechanism of interferon induced priming of the Fas pathway in Fanconi anaemia cells. Biochem Pharmacol 2003;65:833-842.
40. HADJUR S, JIRIK FR. Increased sensitivity of Fancc-deficient hematopoietic cells to nitric oxide and evidence that this species mediates growth inhibition by cytokines. Blood 2003;101:3877-3884.
41. RUPPITSCH W, MEISSLITZER C, HIRSCH-KAUFFMANN M, SCHWEIGER M. Overexpression of thioredoxin in Fanconi anaemia fibroblasts prevents the cytotoxic and DNA damaging effect of mitomycin C and diepoxybutane. FEBS Lett 1998;422:99-102.
42. KONTOU M, ADELFALK C, RAMIREZ MH, RUPPITSCH W, HIRSCH-KAUFFMANN M, SCHWEIGER M. Overexpressed thioredoxin compensates Fanconi anaemia related chromosomal instability. Oncogene 2002;21:2406-2412.
43. MORRELL D, CHASE CL, KUPPER LL, SWIFT M. Diabetes mellitus in ataxia-telangiectasia, Fanconi anaemia, xeroderma pigmentosum, common variable immune deficiency, and severe combined immune deficiency families. Diabetes 1986;35:143-147.
44. SMITH MT. Overview of benzene-induced aplastic anaemia. Eur J Haematol Suppl 1996;60:107-110.
45. UMEGAKI K, SUGISAWA A, SHIN SJ, YAMADA K, SANO M. Different onsets of oxidative damage to DNA and lipids in bone marrow and liver in rats given total body irradiation. Free Radic Biol Med 2001;31:1066-1074.
46. GORDON-SMITH EC, RUTHERFORD TR. Fanconi anaemia - constitutional, familial aplastic anaemia. Baillière's Clin Haematol 1989;2:139-152.
47. BORNMAN L, BALADI S, RICHARD MJ, TYRRELL RM, POLLA BS. Differential regulation and expression of stress proteins and ferritin in human monocytes. J Cell Physiol 1999;178:1-8.
48. KAMINSKY LS, SPIVACK SD. Cytochromes P450 and cancer. Mol Aspects Med 1999;20:70-84.
49. KOVACIC P, JACINTHO JD. Mechanisms of carcinogenesis: focus on oxidative stress and electron transfer. Curr Med Chem 2001;8:773-796.
50. FLOYD RA. The role of 8-hydroguanine in carcinogenesis. Carcinogenesis 1990;9:1447-1450.
51. VLASSARA H, PALACE MR. Diabetes and advanced glycation endproducts. J Intern Med 2002;251:87-101.
52. SHEADER EA, BENSON RS, BEST L. Cytotoxic action of methylglyoxal on insulin-secreting cells. Biochem Pharmacol 2001;61:1381-1386.
53. ROBERTSON RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004;279:42351-42354.
54. KAJIMOTO Y, KANETO H. Role of oxidative stress in pancreatic beta-cell dysfunction. Ann NY Acad Sci 2004;1011:168-176.
55. BLASIAK J, ARABSKI M, KRUPA R, et al. DNA damage and repair in type 2 diabetes mellitus. Mutat Res 2004;554:297-304.
56. CHENG C, ZOCHODNE DW. Sensory neurons with activated caspase-3 survive long-term experimental diabetes. Diabetes 2003;52:2363-2371.
57. GREDILLA R, BARJA G, LOPEZ-TORRES M. Thyroid hormone-induced oxidative damage on lipids, glutathione and DNA in the mouse heart. Free Radic Res 2001;35:417-425.
58. EVANS LM, DAVIES JS, ANDERSON RA, et al. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency. Eur J Endocrinol 2000;142:254-262.
59. PROTA G. Melanins and Melanogenesis. New York: Academic Press, 1992.
60. MEMOLI S, NAPOLITANO A, D'ISCHIA M, MISURACA G, PALUMBO A, PROTA G. Diffusible melanin-related metabolites are potent inhibitors of lipid peroxidation. Biochim Biophys Acta 1997;1346:61-68.
61. NOVELLINO L, NAPOLITANO A, PROTA G. 5,6-Dihydroxyindoles in the Fenton reaction: A model study of the role of melanin precursors in oxidative stress and hyperpigmentary processes. Chem Res Toxicol 1999;12:985-992.
62. SCHALLREUTER KU, LEMKE KR, HILL HZ, WOOD JM. Thioredoxin reductase induction coincides with melanin biosynthesis in brown and black guinea pigs and in murine melanoma cells. J Invest Dermatol 1994;103:820-824.
63. WELLS PG, KIM PM, LAPOSA RR, NICOL CJ, PARMAN T, WINN LM. Oxidative damage in chemical teratogenesis. Mutat Res 1997;396:65-78.
64. HANSEN JM, HARRIS KK, PHILBERT MA, HARRIS C. Thalidomide modulates nuclear redox status and preferentially depletes glutathione in rabbit limb versus rat limb. J Pharmacol Exp Ther 2002;300:768-776.
65. ARAGNO M, PAROLA S, BRIGNARDELLO E, et al. Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats. Diabetes 2000;49:1924-1931.
66. GINSBURG GS, O'TOOLE M, RIMM E, DOUGLAS PS, RIFAI N. Gender differences in exercise-induced changes in sex hormone levels and lipid peroxidation in athletes participating in the Hawaii Ironman triathlon. Clin Chim Acta 2001;305:131-139.
67. SCHMIDT AJ, KRIEG JC, VEDDER H. Differential effects of glucocorticoids and gonadal steroids on glutathione levels in neuronal and glial cell systems. J Neurosci Res 2002;67:544-550.
68. HOWLETT NG, TANIGUCHI T, OLSON S, et al. Biallelic inactivation of BRCA2 in Fanconi anaemia. Science 2002;297:606-609.
69. WANG X, ANDREASSEN PR, D'ANDREA AD. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol Cell Biol 2004;24:5850-5862.
70. LE PAGE F, RANDRIANARISON V, MAROT D, et al. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. Cancer Res 2000;60:5548-5552.
71. PICHIERRI P, ROSSELLI F. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO J 2004;23:1178-1187.
72. DAS KC, DASHNAMOORTHY R. Hyperoxia activates the ATR-Chk1 pathway and phosphorylates p53 at multiple sites. Am J Physiol Lung Cell Mol Physiol 2004;286:L87-97.
73. waf1/cip1 isoform is an early event of cell response to oxidative stress. Cell Death Differ 1998;5:940-945.
74. TYRBERG B, ANACHKOV KA, DIB SA, WANG-RODRIGUEZ J, YOON KH, LEVINE F. Islet expression of the DNA repair enzyme 8-oxoguanosine DNA glycosylase (Ogg1) in human type 2 diabetes. BMC Endocr Disord 2002;2:2.
75. SHEEHAN JM, CRAGG N, CHADWICK CA, POTTEN CS, YOUNG AR. Repeated ultraviolet exposure affords the same protection against DNA photodamage and erythema in human skin types II and IV but is associated with faster DNA repair in skin type IV. J Invest Dermatol 2002;118:825-829.
76. LING G, CHADWICK CA, BERNE B, POTTEN CS, PONTEN J, PONTEN F. Epidermal p53 response and repair of thymine dimers in human skin after a single dose of ultraviolet radiation: effects of photoprotection. Acta Derm Venereol 2001;81:81-86.